These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21367486)

  • 1. [Hypertony and uveitis: 103 cases of uveitis].
    Pogorzalek N; de Monchy I; Gendron G; Labetoulle M
    J Fr Ophtalmol; 2011 Mar; 34(3):157-63. PubMed ID: 21367486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of ocular surface diseases in the management of glaucoma].
    Van Went C; Brasnu E; Hamard P; Baudouin C; Labbé A
    J Fr Ophtalmol; 2011 Apr; 34(4):230-7. PubMed ID: 21439676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center.
    Heinz C; Koch JM; Zurek-Imhoff B; Heiligenhaus A
    Ocul Immunol Inflamm; 2009; 17(4):243-8. PubMed ID: 19657977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of uveitis presenting de novo in the elderly].
    Kirsch O; Lautier-Frau M; Labetoulle M; Offret H; Frau E
    J Fr Ophtalmol; 2003 Sep; 26(7):720-4. PubMed ID: 13130260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypertension and glaucoma associated with scleritis and uveitis. Aspects of epidemiology, pathogenesis and therapy.
    Schlote T; Zierhut M
    Dev Ophthalmol; 1999; 30():91-109. PubMed ID: 10627919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic difficulties in neovascular glaucoma].
    Macarie S; Palko Z
    Oftalmologia; 2006; 50(2):73-6. PubMed ID: 16927763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis.
    Kanda T; Shibata M; Taguchi M; Ishikawa S; Harimoto K; Takeuchi M
    Br J Ophthalmol; 2014 Jul; 98(7):932-6. PubMed ID: 24682184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 10. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ocular hypertension and uveitis. Study of 374 cases of uveitis].
    Saouli N; Brézin AP
    J Fr Ophtalmol; 1999 Nov; 22(9):943-9. PubMed ID: 10609168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
    Nakakura S; Nomura Y; Ataka S; Shiraki K
    J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis.
    Foster CS; Havrlikova K; Baltatzis S; Christen WG; Merayo-Lloves J
    Acta Ophthalmol Scand; 2000 Oct; 78(5):576-9. PubMed ID: 11037918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K; Orgül S; Flammer J
    Curr Med Res Opin; 2003; 19(4):330-5. PubMed ID: 12841926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "usefulness" product: concern for cupping, control, and compliance.
    Worthen DM
    Ann Ophthalmol; 1978 Oct; 10(10):1393-5. PubMed ID: 31127
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular hypertension associated with ocular sarcoidosis.
    Mirza S; Saeed T; Murray PI
    Ocul Immunol Inflamm; 2007; 15(6):447-9. PubMed ID: 18085490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma detection: a three-step technique.
    Weinstock FJ
    Am Fam Physician; 1973 Sep; 8(3):136-41. PubMed ID: 4729711
    [No Abstract]   [Full Text] [Related]  

  • 19. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestation in treated multibacillary Hansen's disease.
    Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
    Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.